HUA MEDICINE-B (02552) announced that on November 28, 2025, the company granted share options to three executive directors and 71 employees under the company's share option plan, which was conditionally approved and adopted on August 26, 2018, and became effective on September 14, 2018. The grant is subject to acceptance by the grantees. The share options entitle the grantees to subscribe for a total of 20 million new shares in the company's share capital, each with a nominal value of $0.001.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.